Manufacturing - Specialty Pharma

France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted...

Nasdaq-listed biopharmaceutical company, Gilead Sciences, is acquiring Germany-based Tubulis, for a total deal value of up to US$5bn. Under the terms of the agreement, Gilead...

Authors Dr Lakshiv Dhingra, Dr Seren Marsh, Abhishek Patel and Dr Victor Chua of Mansfield Advisors consider how the GLP-1 landscape will evolve over...

Family-owned Juvisé Pharmaceuticals, a France-based specialty pharma, has completed a €550m (US$655m) refinancing (including €400m of existing debt and a new €150m capital expenditure...

Angelini Pharma, the pharmaceutical division of multinational privately owned industrial group Angelini Industries, has appointed Sergio Marullo di Condojanni as CEO. Already CEO of...

London and New York-listed global biopharma GSK is to acquire Nasdaq-listed RAPT Therapeutics, a US-based, clinical-stage biopharma dedicated to developing therapies for patients living...

Oxford-based Dark Blue Therapeutics, a discovery and development biotech spinout Nasdaq-listed multinational biopharma Amgen. The acquisition adds to Amgen's portfolio an investigational small molecule...

Insilico Medicine, a clinical-stage drug discovery and development company, listed on the Hong Kong Stock Exchange at the end of December, becoming the first...

Nasdaq Stockholm-listed Swedish Orphan Biovitrum (SOBI), a global biopharma company, is to acquire US-based Arthrosi Therapeutics, a clinical-stage biotech company focused on the development of...

Curium, a France-based producer of radiopharmaceuticals, and global investment firm CapVest Partners have announced the recapitalization of Curium via a new Continuation Vehicle (CV). ...